Contract Manufacturing Services

FDA Inspectors Cited Critical Problems at Emergent Facility

April 09, 2021

Even before Emergent disclosed that it had to discard 15 million doses of the J&J vaccine drug substance, FDA inspectors had uncovered multiple deficiencies and quality control issues.

J&J to Take Over Its Product Manufacturing at Emergent Facility

April 05, 2021

Following a manufacturing mix-up, J&J will extend its oversight at Emergent’s Maryland facility; AstraZeneca manufacturing to relocate.

Advanced Manufacturing Technologies Shift Outside the Box

April 03, 2021

Intensified and distributed manufacturing approaches create flexible, local capacity.

Celonic Group to Manufacture CureVac’s mRNA COVID Vaccine Candidate

March 30, 2021

Celonic will manufacture CvnCoV at its facility in Germany.

Digital Inventory Platform Improves Data Access

March 03, 2021

A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Avid Bioservices Expands Biologics Manufacturing Capacity

February 22, 2021

The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.

Wavelength Pharmaceuticals Acquires Vanamali Organics

February 18, 2021

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Cascade Chemistry Expands API Manufacturing Capacity

February 18, 2021

Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.